CDKN2A

Description 
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) CDK4 inhibitor p16-INK4 MTS-1 cell cycle negative regulator beta cyclin-dependent kinase 4 inhibitor A cyclin-dependent kinase inhibitor 2A, isoform 4 cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3 cyclin-dependent kinase inhibitor p16 multiple tumor suppressor 1 p16-INK4 p16-INKa

This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants.

This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, MDM1, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control.

This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene.

Aliases 
ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, TP16, p14, p14ARF, p16, p16INK4, p16INK4a, p19, p19Arf
Chromosomal Locations 
9p21